MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma

Changzheng Liu1, Jia Yu, Shuangni Yu

  • 1National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Department of Biochemistry, Beijing, PR China.

Abstract

Insights

MicroRNA-21 promotes hepatocellular carcinoma by targeting PTEN, PDCD4, and RECK, increasing cell proliferation and invasion. Suppressing microRNA-21 offers a potential treatment strategy for liver cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNA-21 (miR-21) is implicated in tumorigenesis, but its specific role and targets in human hepatocellular carcinoma (HCC) remain unclear.
  • Direct evidence linking miR-21 function to phenotypic alterations in HCC is lacking.

Purpose of the Study:

  • To investigate the function of microRNA-21 as an oncomir in HCC.
  • To elucidate the relationship between miR-21, its targets (PTEN, PDCD4, RECK), and phenotypic changes in HCC.

Main Methods:

  • Rescue experiments using anti-microRNA-21 and siRNA to modulate miR-21 levels and target proteins.
  • Analysis of phenotypic alterations including apoptosis, invasion, and cell cycle progression.
  • Investigation of signaling pathways affected by miR-21 suppression, including Akt signaling.

Main Results:

  • Hepatocellular carcinoma tissues exhibit elevated miR-21 levels and reduced expression of PTEN, PDCD4, and RECK.
  • Suppression of PTEN and PDCD4 by anti-miR-21 treatment led to decreased apoptosis and increased invasion.
  • Silencing of RECK resulted in increased invasion; miR-21 knockdown altered Akt signaling, p21, and MMP family expression.

Conclusions:

  • MicroRNA-21 targets PTEN, PDCD4, and RECK, simultaneously promoting HCC cell proliferation, inhibiting apoptosis, and enhancing invasiveness.
  • Targeting miR-21 is a promising therapeutic strategy for HCC, potentially involving modulation of multiple downstream targets and pathways.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...